CLPT - צמיחת הכנסות ב-12 חודשים נגררים ClearPoint Neuro, Inc.

ClearPoint Neuro, Inc. (CLPT) focuses on the expansion of single-use consumables for neuronavigation and gene therapy. The annual sales revenue trend over four quarters illustrates the current trajectory, where the 32.50 mark characterizes this parameter. Dominance in the MRI-guided surgery niche protects the business from dumping, although the shortage of specialized chips resulting from trade wars creates supply chain risks.

For high-precision MRI-navigation systems manufacturer ClearPoint Neuro (CLPT), revenue depends directly on the adoption rate of specialized electronics in neurosurgery. By analyzing this trailing twelve-month (TTM) revenue change chart, an investor can track sales dynamics over a rolling 12-month period relative to the previous year, allowing for a real-time assessment of business expansion and the timely identification of capital drawdown risks should market demand decelerate.